GLP-1 Weight Loss Timeline: A Month-by-Month Guide
Weight loss isn't linear. Here is a realistic, data-backed look at what happens to your body during the first 12 months on GLP-1 therapy — based on the STEP-1 and SURMOUNT-1 clinical trials.
Key Takeaways (Clinical Data)
- Semaglutide (Ozempic/Wegovy): 14.9% average body weight loss over 68 weeks in STEP-1
- Tirzepatide (Mounjaro/Zepbound): 20.9% average body weight loss over 72 weeks in SURMOUNT-1
- Peak weight loss rate: Months 2-6, then gradual plateau by months 9-12
- Visible changes: Most patients notice body shape changes by month 3-4
Understanding the Titration Phase
Most GLP-1 medications require a "titration" period — starting at a low dose and increasing monthly to minimize side effects. This means dramatic weight loss usually doesn't happen in Week 1. For Ozempic, you start at 0.25mg and gradually increase to a therapeutic dose of 1.0-2.4mg over 4-8 weeks. For Mounjaro, titration goes from 2.5mg up to 15mg.
Clinical Trial Results: Weight Loss by Timepoint
The table below shows average weight loss at key milestones from the two landmark clinical trials. Results are for a 200 lb starting weight.
| Timepoint | Semaglutide 2.4mg (STEP-1) | Tirzepatide 15mg (SURMOUNT-1) |
|---|---|---|
| Month 1 | -2 to 4 lbs (1-2%) | -3 to 5 lbs (1.5-2.5%) |
| Month 3 | -10 to 14 lbs (5-7%) | -14 to 22 lbs (7-11%) |
| Month 6 | -20 to 24 lbs (10-12%) | -28 to 34 lbs (14-17%) |
| Month 9 | -24 to 28 lbs (12-14%) | -34 to 40 lbs (17-20%) |
| Month 12 | -26 to 30 lbs (13-15%) | -38 to 42 lbs (19-21%) |
Source: STEP-1 (Wilding et al., NEJM, 2021) and SURMOUNT-1 (Jastreboff et al., NEJM, 2022). Values are population averages — individual results vary.
The Full Month-by-Month Breakdown
Month 1: The Adjustment
0.25mg semaglutide
2-4 lbs (1-2%)
Nausea, reduced appetite
You're on the lowest starting dose. The goal is adjustment, not transformation. Most patients notice "food noise" getting quieter — that constant background hum of thinking about food begins to fade. Nausea affects 40-50% of patients in the first 2 weeks but usually subsides. Much of the early weight loss is water weight as inflammation decreases.
Months 2-3: The Acceleration
0.5-1.0mg semaglutide
10-14 lbs (5-7%)
Decreasing nausea, constipation
This is where the medication starts to work. You're titrating up to therapeutic doses, and the weight loss rate increases to 1-2 lbs per week. Appetite suppression becomes consistent — you get full much faster and portions naturally shrink. Pants begin fitting looser. Side effects from month 1 typically diminish as your body adjusts, though some GI symptoms may recur briefly with each dose increase.
Months 4-5: The Visible Change
1.0-1.7mg semaglutide
16-20 lbs (8-10%)
Mostly resolved, mild fatigue
This is typically when friends and family start commenting. You've likely lost 1-2 clothing sizes, your face looks noticeably slimmer, and your waist circumference has dropped measurably. The 5-10% body weight loss threshold is medically significant — research shows this is enough to improve blood pressure, blood sugar, and cholesterol levels. You're at or approaching the full therapeutic dose.
Month 6: The "New You"
Peak Loss Rate1.7-2.4mg semaglutide
20-24 lbs (10-12%)
Generally minimal
Month 6 is a major milestone. Most patients on semaglutide have lost approximately 10-12% of their body weight, and those on tirzepatide may have lost 14-17%. You've likely dropped 2-3 clothing sizes. The STEP-1 trial showed the majority of weight loss occurs in this first 6-month window. Body composition is shifting — you're losing both visceral (deep belly) fat and subcutaneous fat. This is where the transformation becomes undeniable.
Months 7-9: The Deceleration
Maintenance dose (stable)
24-28 lbs (12-14%)
Body composition, muscle
The rate of weight loss begins to slow — this is completely normal and expected, not a sign the medication has "stopped working." Your body is approaching a new metabolic equilibrium. This is the ideal time to focus on body composition: increasing protein intake (0.7-1g per pound of body weight) and adding resistance training 2-3 times per week to preserve lean muscle mass. Research shows 25-40% of weight lost on GLP-1 medications can come from lean mass if not actively countered with exercise.
Months 10-12: The Plateau
Maintenance dose (stable)
26-30 lbs (13-15%)
Maintenance, lifestyle habits
Most patients reach their maximum weight loss between months 10-15. The scale may not move much, but body composition can still be improving if you're exercising. This is the critical phase for building the lifestyle habits that will sustain your results long-term. The STEP-1 trial extension showed that patients who discontinued semaglutide regained approximately two-thirds of the lost weight within a year, underscoring the importance of continued treatment and habit formation.
Ozempic vs. Mounjaro: Timeline Comparison
Both medications follow a similar weight loss curve shape, but tirzepatide (Mounjaro/Zepbound) consistently produces greater total loss at every timepoint due to its dual GIP/GLP-1 mechanism.
| Feature | Ozempic/Wegovy | Mounjaro/Zepbound |
|---|---|---|
| Active ingredient | Semaglutide | Tirzepatide |
| Mechanism | GLP-1 agonist | Dual GIP/GLP-1 agonist |
| Avg. loss at 6 months | 10-12% | 14-17% |
| Avg. loss at 12+ months | 14.9% | 20.9% |
| Titration period | 4-8 weeks | 4-8 weeks |
| Key clinical trial | STEP-1 | SURMOUNT-1 |
Side Effects Timeline
Understanding when side effects peak and resolve helps set realistic expectations.
1-4
Nausea & Appetite Changes
40-50% of patients experience nausea. Appetite decreases noticeably. Eat smaller, more frequent meals to manage GI symptoms.
4-12
GI Adjustment & Dose Increases
Nausea typically decreases but may recur briefly with each dose escalation. Constipation or diarrhea may occur. Stay hydrated.
12-24
Stabilization
Most GI side effects resolve as your body fully adjusts. Some patients report acid reflux or hair thinning (related to rapid weight loss, not the drug itself).
24+
Long-Term Maintenance
Side effects are generally minimal at stable doses. Focus shifts to maintaining lean muscle mass, adequate protein, and sustainable habits.
5 Tips to Maximize Your GLP-1 Results
Prioritize protein (0.7-1g per pound body weight)
Protein preserves lean muscle mass during weight loss and keeps you satiated longer. This is the single most impactful dietary change you can make.
Add resistance training 2-3x per week
Without strength training, up to 40% of weight lost can come from lean mass. Even basic bodyweight exercises help preserve muscle.
Stay hydrated (8+ glasses daily)
GLP-1 medications slow gastric emptying and can cause constipation. Adequate water intake minimizes GI side effects.
Get 7-9 hours of sleep
Sleep deprivation increases ghrelin (hunger hormone) and reduces the effectiveness of appetite-suppressing medications.
Track progress with photos, not just the scale
Body composition changes (losing fat, retaining muscle) don't always show on the scale. Monthly progress photos reveal changes the numbers miss.
Related Reading
Frequently Asked Questions
How fast does Ozempic work for weight loss?
Most patients notice reduced appetite within the first 1-2 weeks on Ozempic. Measurable weight loss typically begins by month 1 (2-4 lbs), accelerates during months 2-3 as doses increase, and reaches peak efficacy around month 6 with ~10% body weight loss on semaglutide.
What is the GLP-1 titration phase?
The titration phase is a period of gradually increasing your GLP-1 medication dose to minimize side effects. For Ozempic, you start at 0.25mg and increase monthly. Most patients don't reach full therapeutic doses until months 2-3, which is why significant weight loss is typically delayed.
How much weight can I lose on GLP-1 medication in 6 months?
By month 6, most patients on semaglutide (Ozempic/Wegovy) have lost approximately 10% of their body weight. Patients on tirzepatide (Mounjaro/Zepbound) may lose 15% or more. For a 200 lb person, that translates to 20-30+ lbs depending on the medication and dose.
When will people notice my weight loss on Ozempic?
Most patients report that friends and family begin noticing visible changes around months 3-4, when total weight loss typically reaches 5-10% of starting body weight. By month 6, the changes are usually unmistakable — looser clothing, slimmer face, and visible waist reduction.
Does weight loss on Ozempic slow down over time?
Yes. Weight loss on GLP-1 medications follows a curve — fastest during months 2-6, then gradually plateauing between months 9-15. The STEP-1 trial showed most weight loss occurred in the first 40 weeks (about 9 months), with patients reaching a plateau around week 60. This is normal and expected.
What are the most common side effects of Ozempic by month?
Month 1: Nausea (40-50% of patients), reduced appetite, mild fatigue. Months 2-3: Nausea typically decreases; constipation or diarrhea may occur during dose increases. Months 4-6: Most GI side effects resolve. Months 6+: Side effects are generally minimal at stable doses.
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. GLP-1 medications like Ozempic (semaglutide) and Mounjaro (tirzepatide) are prescription drugs that should only be used under the supervision of a licensed healthcare provider. The weight loss timelines cited are based on population averages from the STEP-1 (Wilding et al., NEJM, 2021) and SURMOUNT-1 (Jastreboff et al., NEJM, 2022) clinical trials and may not reflect individual results. Side effects, drug interactions, and contraindications exist. Always consult your doctor before starting, stopping, or changing any medication. BeforeAfterFit is not a medical provider and does not prescribe medications.